The role of hippocampal iron concentration and hippocampal volume in age-related differences in memory

Cerebral Cortex

Volumn 23, Issue 7, 2013, Pages 1533-1541

  Rodrigue, Karen M ^a   Daugherty, Ana M ^b   Haacke, E Mark ^c   Raz, Naftali ^b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b Institute of Gerontology   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

Author keywords

aging; brain; hippocampus; memory; T2

Indexed keywords

IRON;

ADULT; AGED; ARTICLE; BRAIN SIZE; CAUDATE NUCLEUS; FEMALE; HIPPOCAMPUS; HUMAN; IN VIVO STUDY; MALE; MEMORY; NORMAL HUMAN; OXIDATIVE STRESS; PERFORMANCE; PRIORITY JOURNAL; PULSE PRESSURE; SCORING SYSTEM; STRIATE CORTEX; STRUCTURAL EQUATION MODELING;

AGING; BRAIN; HIPPOCAMPUS; MEMORY; T2*;

ADULT; AGED; AGED, 80 AND OVER; AGING; FEMALE; HIPPOCAMPUS; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IRON; MAGNETIC RESONANCE IMAGING; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; YOUNG ADULT;

EID: 84878857244     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhs139     Document Type: Article

References (61)

1. Ayaz M, Boikov AS, Haacke EM, Kido DK, Kirsch WM. 2010. Imaging cerebral microbleeds using susceptibility weighted imaging: one step toward detecting vascular dementia. J Magn Reson Imaging. 31:142-148.
2. Bartzokis G. 2011. Alzheimer's disease as homeostatic responses to age-related myelin breakdown. Neurobiol Aging. 32:1341-1371.
3. Bartzokis G, Lu P, Tingus K, Peters D, Amar CP, Tishler TA, Finn JP, Villablanca P, Altshuler LL, Mintz J et al. 2011. Gender and iron genes may modify associations between brain iron and memory in healthy aging. Neuropsychpharmacology. 36:1375-1384.
4. Bartzokis G, Tishler T, Lu P, Villablanca P, Altshuler LL, Carter M, Huang D, Edwards N, Mintz J. 2007. Brain ferritin iron may influence age-and gender-related risks of neurodegeneration. Neurobiol Aging. 28:414-423.
5. Berg D, Kruger R, RieB R, Riederer P. 2007. Parkinson's disease. In: Youdim M, Riederer P, Mandel S, Battistin L, editors. Handbook of neurochemistry and molecular neurobiology: degenerative disease of the nervous system. 3rd ed. New York (NY): Springer. p. 1-20.
6. Bourgeat P, Chetelat G, Villemagne VL, Fripp J, Raniga P, Pike K, Acosta O, Szoeke C, Ourselin S, Ames D. 2010. Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia. Neurology. 74:121-127.
7. Braak H, Braak E. 1991. Neuropathological stageing of Alzheimerrelated changes. Acta Neuropathol. 82:239-259.
8. Cherubini A, Peran P, Caltagirone C, Sabatini U, Spalletta G. 2009. Aging of subcortical nuclei: microstructural, mineralization and atrophy modifications measured in vivo using MRI. NeuroImage. 48:29-36.
9. Chételat G, Villemagne VL, Bourgeat P, Pike KE, Jones G, Ames D, Ellis KA, Szoeke C, Martins RN, O'Keefe GJ et al.; Australian Imaging Biomarkers and Lifestyle Research Group. 2010. Relationship between atrophy and ?-amyloid deposition in Alzheimer disease. Ann Neurol. 67:317-324.
10. Collingwood JF, Chong RK, Kasama T, Cervera-Gontard L, Dunin-Borkowski RE, Perry G, Pósfai M, Siedlak SL, Simpson ET, Smith MA et al. 2008. Three-dimensional tomographic imaging and characterization of iron compounds within Alzheimer's plaque core material. J Alzheimers Dis. 14:235-245.
11. Craik FIM. 1977. Age differences in human memory. In: Birren JE, Schaie KW, editors. Handbook of the psychology of aging. New York (NY): Van Nostrand Reinhold. p. 384-420.
12. Deibel MA, Ehmann WD, Markesbery WR. 1996. Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress. J Neurol Sci. 143:137-142.
13. Ding B, Chen K, Ling H, Sun F, Li X, Wan T, Chai WM, Zhang H, Zhan Y, Guan YJ. 2009. Correlation of iron in the hippocampus with MMSE in patients with Alzheimer's disease. J Magn Reson Imaging. 29:793-798.
14. Duyn JH, van Gelderen P, Li TQ, de Zwart JA, Koretsky AP, Fukunaga M. 2007. High-field MRI of brain cortical substructure based on signal phase. Proc Natl Acad Sci USA. 104:11796-11801.
15. Falangola MF, Lee SP, Nixon RA, Duff K, Helpern JA. 2005. Histological co-localization of iron in Abeta plaques of PS/APP transgenic mice. Neurochem Res. 20:201-205.
16. Folstein M, Flostein S, McHugh P. 1975. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 12:189-198.
17. Greenberg SM, Vernooij MW, Cordonnier C, Viswanathan A, Al-Shahi Salman R, Warach S, Launer LJ, Van Buchem MA, Breteler MM, Microbleed Study Group. 2009. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol. 8:165-174.
18. Haacke EM, Cheng NYC, House MJ, Liu Q, Neelavalli J, Ogg RJ, Khan A, Ayaz M, Kirsch W, Obenaus A. 2005. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging. 23:1-25.
19. Hackert VH, den Haijer T, Oudkerk M, Koudstaal PJ, Hofman A, Breteler MM. 2002. Hippocampal head size associated with verbal memory performance in nondemented elderly. NeuroImage. 17:1365-1372.
20. Hallgren B, Sourander P. 1958. The effect of age on the non-haemin iron in the human brain. J Neurochem. 3:41-51.
21. Hamilton M, Van Remmen H, Drake J, Yang H, Guo Z, Kewitt K, Walter C, Richardson A. 2001. Does oxidative damage to DNA increase with age? Proc Natl Acad Sci. 98:10469-10474.
22. Jack CR, Jr, Lowe VJ, Weigand SD, Wiste HJ, Senjem ML, Knopman DS, Shiung MM, Gunter JL, Boeve BF, Kemp BJ. 2009. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain. 132:1355-1365.
23. James L, Brett J. 1984. Mediators, moderators, and test for mediation. J Appl Psychol. 69:307-321.
24. Katzman R, Terry R, DeTeresa R, Brown T, Davies P, Fuld P, Renbing X, Peck A. 1988. Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol. 23:138-144.
25. Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR. 1998. Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci. 158:47-52.
26. Maaroufi K, Ammari M, Jeljeli M, Roy V, Sakly M, Abdelmelek H. 2009. Impairment of emotional behavior and spatial learning in adult Wistar rats by ferrous sulfate. Physiol Behav. 96:343-349.
27. Martin W, Ye F, Allen P. 1998. Increasing striatal iron content associated with normal aging. Mov Disord. 13:281-286.
28. Mills E, Dong XP, Wang F, Xu H. 2010. Mechanisms of brain iron transport: insight into neurodegeneration and CNS disorders. Future Med Chem. 2:51-64.
29. Ogawa S, Lee TM, Nayak AS, Glynn P. 1990. Oxygenation-sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields. Magn Reson Med. 14:68-78.
30. Oldfield R. 1971. The assessment and analysis of handedness. Neuropsychologica. 9:97-113.
31. Ordidge R, Gorell J, Deniau J, Knight R, Helpern J. 1994. Assessment of relative brain iron concentrations using T2-weighted and T2-weighted MRI at 3 tesla. Magn Reson Med. 32:335-341.
32. Pauling L, Coryell CD. 1936. The magnetic properties and structure of hemoglobin, oxyhemoglobin and carbonmonoxyhemoglobin. Proc Natl Acad Sci USA. 22:210-216.
33. Peran P, Cherubini A, Luccichenti G, Hagberg G, Demonet J, Rascol O, Celsis P, Caltagirone C, Spalletta G, Sabatini U. 2009. Volume and iron content in basal ganglia and thalamus. Human Brain Mapp. 30:2667-2675.
34. Pfefferbaum A, Adalsteinsson E, Rohlfing T, Sullivan E. 2009. MRI estimates of brain iron concentration in normal aging: comparison of field-dependent (FDRI) and phase (SWI) methods. Neuro-Image. 47:493-500.
35. Price JL, McKeel DW, Jr, Buckles VD, Roe CM, Xiong C, Grundman M, Hansen LA, Petersen RC, Parisi JE, Dickson DW et al. 2009. Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiol Aging. 30: 1026-1036.
36. Radloff L. 1977. The CES-D scale: a self-report depression scale for research in the general population. J Struct Biol. 153:42-54.
37. Raykov T, Marcoulides G. 2006. A first course in structural equation modeling. 2nd ed. Mahwah, NJ: Lawrence Erlbaum.
38. Raz N, Ghisletta P, Rodrgiue K, Kennedy K, Lindenberger U. 2010. Trajectories of brain aging in middle-age and older adults: regional and individual differences. NeuroImage. 51:501-511.
39. Raz N, Lindenberg U, Rodrigue KM, Kennedy KM, Head D, Williamson A, Dahle C, Gerstorf D, Acker JD. 2005. Regional brain changes in aging healthy adults: general trends, individual differences, and modifiers. Cereb Cortex. 15:1676-1689.
40. Raz N, Rodrigue KM. 2006. Differential aging of the brain: patterns, cognitive correlates and modifiers. Neurosci Biobehav Rev. 30:730-748.
41. Raz N, Rodrigue KM, Haacke EM. 2007. Brain aging and its modifiers: insights from in vivo neuromorphometry and susceptibility weighted imaging. Ann N Y Acad Sci. 1097:84-93.
42. Rodrigue KM, Haacke EM, Raz N. 2011. Differential effects of age and history of hypertension on regional brain volumes and iron. NeuroImage. 54:750-759.
43. Rodrigue KM, Kennedy KM. 2011. The cognitive consequences of structural changes to the aging brain. In: Schaie KW, Willis SL, editors. Handbook of the psychology of aging. 7th ed., Ch 5. New York (NY): Elsevier. p. 73-92.
44. Rodrigue KM, Kennedy KM, Devous MD, Sr, Rieck JR, Hebrank AC, Diaz-Arrastia R, Mathews D, Park DC. 2012. Amyloid deposition in healthy aging: regional deposition and cognitive consequences. Neurology. 78:387-395. Rodrigue KM, Kennedy KM, Park DC. 2009. Beta-amyloid deposition and the aging brain. Neuropsychol Rev. 19:436-450.
45. Rombouts SA, Scheltens P, Kuijer JP, Barkhof F. 2007. Whole brain analysis of T2 weighted baseline FMRI signal in dementia. Hum Brain Mapp. 28:1313-1317.
46. Rowe CC, Ng S, Ackermann U, Gong SJ, Pike K, Savage G, Cowie TF, Dickinson KL, Maruff P, Darby D et al. 2007. Imaging beta-amyloid burden in aging and dementia. Neurology. 68:1718-1725.
47. Schenck JF, Zimmerman EA. 2004. High-field magnetic resonance imaging of brain iron: birth of a biomarker? NMR Biomed. 17:433-445.
48. Shmueli K, de Zwart J, van Gelderen P, Li T-Q, Dodd SJ, Duyn JH. 2009. Magnetic susceptibility mapping of brain tissue in vivo using MRI phase data. Magn Reson Med. 62:1510-1522.
49. Shrout P, Fleiss J. 1979. Intraclass correlations: uses in assessing raters reliability. Psychol Bull. 86:420-428.
50. Siemonsen S, Finsterbusch J, Matschke J, Loernzen A, Ding X, Fiehler J. 2008. Age-dependent normal values of T2*and T20 in brain parenchyma. Am J Neuroradiol. 29:950-955.
51. Small BJ, Fratiglioni L, Vitanen M, Winblad B, Backman L. 2000. The course of cognitive impairment in preclinical Alzheimer disease: three-and 6-year follow-up of a population-based sample. Arch Neurol. 57:839-844.
52. Squire LR. 1987. Memory and brain. New York (NY): Oxford University Press.
53. Sullivan EV, Adalsteinsson E, Rohling T, Pfefferbaum A. 2009. Relevance of iron deposition in deep gray matter brain structures to cognitive and motor performance in healthy elderly men and women: exploratory findings. Brain Imaging Behav. 3:167-175.
54. Thomas L, Boyoko O, Anthony D, Burger P. 1993. MR detection of brain iron. Am J Neuroradiol. 14:1043-1048.
55. Thompson CM, Markesbery WR, Ehmann WD, Mao YX, Vance DE. 1988. Regional brain trace-element studies in Alzheimer's disease. Neurotoxicol. 9:1-7.
56. Van Petten C. 2004. Relationship between hippocampal volume and memory ability in healthy individuals across the lifespan: review and meta-analysis. Neuropsychologia. 42:1394-1413.
57. Wechsler D. 1987. Manual for Wechsler Memory Scale-Revised. San Antonio (TX): Psychological Corporation.
58. Woodcock RW, Johnson MB. 1989. Woodcock-Johnson psychoeducational battery-revised. Allen (TX): DLM Teaching Resources.
59. Yao B, Li TQ, Gelderen P, Shmueli K, de Zwart JA, Duyn JH. 2009. Susceptibility contrast in high field MRI of human brain as a function of tissue iron content. NeuroImage. 44:1259-1266.
60. Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR. 2004. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci. 5:863-873.
61. Zhang S, Wang J, Song N, Xie J, Jiang H. 2009. Up-regulation of divalent metal transporter 1 is involved in 1-methyl-4-phenylpyridinium (MPP+)-induced apoptosis in MES23.5 cells. Neurobiol Aging. 30:1466-1476.